Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 4:33 AM
Ignite Modification Date: 2025-12-26 @ 3:35 AM
NCT ID: NCT03559218
Description: All SAEs should be reported to the study sponsor within 24 hours of the investigator being aware of the event and reported to the IRB in accordance with IRB requirements.
Frequency Threshold: 0
Time Frame: Subjects were monitored throughout the course of radiation therapy (4-6 weeks) with a 4-week follow-up visit.
Study: NCT03559218
Study Brief: KeraStat(R) Cream for Radiation Dermatitis
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Standard of Care Patients undergoing radiation therapy for breast cancer will be provided instructions for radiation dermatitis per institutional standard of care Standard of care: Patients will be instructed to follow institutional standard of care for radiation dermatitis 0 None 0 11 0 11 View
KeraStat Cream Patients undergoing radiation therapy for breast cancer will be provided KeraStat Cream for twice daily application. KeraStat(R) Cream: KeraStat Cream is a cream wound dressing that contains 5% keratin. 0 None 0 13 0 13 View
Serious Events(If Any):
Other Events(If Any):